Genentech And Roche Showcase Trontinemab, NLRP3 Inflammasome Research And Blood-Based Diagnostics Across Integrated Pharmaceutical And Diagnostics Portfolio At AAIC

Benzinga Newsdesk www.benzinga.com Neutral 90.6%

Neg 0% Neu 90.6% Pos 0%

Five oral presentations in a Featured Research Session will highlight trontinemab, including new long-term data from Phase Ib/IIa Brainshuttle AD study and design of Phase III PrevenTRON study in preclinical Alzheimer’s
New data on Roche’s CE mark Elecsys pTau217 blood test will be presented on its use for Alzheimer's diagnosis in both primary and secondary care

Comments

No comments yet. Be the first!